Evidence map›Paper›PMID 36356031›Full record

ArticleToxins2022

Characterization of a Family of Scorpion Toxins Modulating Ca

Jean-Luc Morel, Nathalie Mokrzycki, Guy Lippens, Hervé Drobecq, Pierre Sautière, Michel Hugues

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jean-Luc MorelUniv. Bordeaux, CNRS, INCIA, UMR 5287, EPHE, F33000 Bordeaux, France.ORCID 0000-0001-8079-6851
Nathalie MokrzyckiUniv. Lille, Institut Pasteur de Lille, F59000 Lille, France.
Guy LippensToulouse Biotechnology Institute (TBI), Université de Toulouse, CNRS, INRAE, INSA, 31077 Toulouse, France.
Hervé DrobecqUniv. Lille, CNRS, UMR 9017, INSERM U1019, CHRU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille, F59000 Lille, France.
Pierre SautièreIndependent Researcher, F59000 Lille, France.
Michel HuguesIndependent Researcher, F33000 Bordeaux, France.
Centre National de la Recherche Scientifique · FRUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pharmacology of calcium-activated chloride current is not well developed. Peptides from scorpion venom present potent pharmacological actions on ionic conductance used to characterize the function of channels but can also be helpful to develop organic pharmacological tools. Using electrophysiological recording coupled with calcium measurement, we tested the potent effect of peptides extracted from

Indexed as

Scorpion VenomsAnimalsCalciumChloride ChannelsChloridesMyocytes, Smooth MusclePeptidesRatsCalciumChloride ChannelsChloridesPeptidesScorpion Venomsanimal toxinscalcium-activated chloride channelscorpion venomvascular smooth muscle

Identifiers

PMID36356031
PMCPMC9699600
OpenAlexW4308694168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.